Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6994)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through May 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fornaro L, Caparello C, Vivaldi C, Rotella V, Musettini G, Falcone A, Baldini E, Masi G. Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review. World J Gastroenterol 2014; 20(20): 6081-6091 [PMID: 24876730 DOI: 10.3748/wjg.v20.i20.6081] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6081.htm |
| Number | Citing Articles |
| 1 |
Gianluca Masi, Caterina Vivaldi, Lorenzo Fornaro, Sara Lonardi, Piero Buccianti, Aldo Sainato, Lorenzo Marcucci, Angelo Martignetti, Emanuele Damiano Luca Urso, Maura Castagna, Gabriella Fontanini, Francesca Bergamo, Gianna Musettini, Lucio Urbani, Elisa Sensi, Riccardo Balestri, Sabrina Montrone, Francesco Pasqualetti, Chiara Cremolini, Antonello Di Paolo, Vittorina Zagonel, Alfredo Falcone. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial. European Journal of Cancer 2019; 110: 32 doi: 10.1016/j.ejca.2019.01.006
|
| 2 |
K. Wilson, M. Flood, V. Narasimhan, T. Pham, S. Warrier, R. Ramsay, M. Michael, A. Heriot. Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. European Journal of Surgical Oncology 2021; 47(8): 1862 doi: 10.1016/j.ejso.2021.03.245
|
| 3 |
Jian Xiao, Zexian Chen, Wenyun Li, Zuli Yang, Yan Huang, Jian Zheng, Yanhong Deng, Lei Wang, Donglin Ren, Junsheng Peng, Ping Lan, Jianping Wang. Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial. Cancer Chemotherapy and Pharmacology 2015; 76(1): 21 doi: 10.1007/s00280-015-2763-2
|
| 4 |
Emmanouil Fokas, Maria Antonietta Gambacorta, Claus Rödel, Vincenzo Valentini. Radiation Oncology. 2018; : 1 doi: 10.1007/978-3-319-52619-5_47-1
|
| 5 |
Sang Woo Park, Jin Soo Kim, Ji Yeon Kim, Kyung Ha Lee. Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes. Annals of Surgical Treatment and Research 2018; 94(6): 306 doi: 10.4174/astr.2018.94.6.306
|
| 6 |
Wei Feng, Bin Yu, Zhenya Zhang, Juan Li, Yuxiang Wang. Current status of total neoadjuvant therapy for locally advanced rectal cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(6): 546 doi: 10.1111/ajco.13640
|
| 7 |
Rene Warschkow, Sabrina M. Ebinger, Walter Brunner, Bruno M. Schmied, Lukas Marti. Survival after Abdominoperineal and Sphincter-Preserving Resection in Nonmetastatic Rectal Cancer: A Population-Based Time-Trend and Propensity Score-Matched SEER Analysis. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/6058907
|
| 8 |
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, Cynthia Aristei, Carlotta Becherini, Liliana Belgioia, Michela Buglione, Luciana Caravatta, Rolando Maria D’Angelillo, Andrea Riccardo Filippi, Michele Fiore, Domenico Genovesi, Carlo Greco, Lorenzo Livi, Stefano Maria Magrini, Giulia Marvaso, Rosario Mazzola, Icro Meattini, Anna Merlotti, Isabella Palumbo, Stefano Pergolizzi, Sara Ramella, Umberto Ricardi, Elvio Russi, Marco Trovò, Alessandro Sindoni, Vincenzo Valentini, Renzo Corvò. Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. Critical Reviews in Oncology/Hematology 2019; 134: 87 doi: 10.1016/j.critrevonc.2018.11.005
|
| 9 |
Chihiro Kanno, Tetsuharu Kaneko, Manabu Endo, Takehiro Kitabatake, Tomoko Sakuma, Yoshiaki Kanaya, Yuki Watanabe, Hiroshi Hasegawa. Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism 2021; 39(3): 423 doi: 10.1007/s00774-020-01170-6
|
| 10 |
|
| 11 |
Carmine Pinto, Maurizio Di Bisceglie, Francesca Di Fabio, Annamaria Bochicchio, Tiziana Latiano, Stefano Cordio, Gerardo Rosati, Carlo Aschele, Antonella Marino, Francesca Bergamo, Sara Bustreo, Luca Frassineti, Fortunato Ciardiello, Angela Damato, Stefania Giaquinta, Daniela Baldari, Luca Boni. Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03). The Oncologist 2018; 23(8): 912 doi: 10.1634/theoncologist.2017-0484
|
| 12 |
Laura Melina Fernandez, Guilherme Pagin São Julião, Bruna Borba Vailati, Angelita Habr-Gama, Rodrigo O. Perez. Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME). 2019; : 31 doi: 10.1007/978-3-030-11572-2_4
|
| 13 |
Alan Su, Rodrigo Pedraza, Hagen Kennecke. Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer. Current Oncology 2023; 30(4): 3672 doi: 10.3390/curroncol30040279
|
| 14 |
Xin Yu, Qiao‐xuan Wang, Wei‐wei Xiao, Hui Chang, Zhi‐fan Zeng, Zhen‐hai Lu, Xiao‐jun Wu, Gong Chen, Zhi‐zhong Pan, De‐sen Wan, Pei‐rong Ding, Yuan‐hong Gao. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single‐institute phase II study. Cancer Communications 2018; 38(1): 1 doi: 10.1186/s40880-018-0294-z
|
| 15 |
T.A. Greenhalgh, C. Dearman, R.A. Sharma. Combination of Novel Agents with Radiotherapy to Treat Rectal Cancer. Clinical Oncology 2016; 28(2): 116 doi: 10.1016/j.clon.2015.11.002
|
| 16 |
Chihiro Kanno, Momoyo Kojima, Yuki Watanabe, Ryosuke Honda, Yu Tezuka, Natsuko Ishida, Tetsuharu Kaneko. Molecular targeted drugs affect the development of antiresorptive‐related osteonecrosis of the jaw in patients with lung and kidney cancers. International Journal of Cancer 2025; doi: 10.1002/ijc.35439
|
| 17 |
Kentaro Ochiai, Neal Bhutiani, Atsushi Ikeda, Abhineet Uppal, Michael White, Oliver Peacock, Craig Messick, Brian Bednarski, Yi-Qian You, John Skibber, George Chang, Tsuyoshi Konishi. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?. Cancers 2024; 16(11): 2093 doi: 10.3390/cancers16112093
|
| 18 |
Angelita Habr-Gama, Laura M Fernandez, Rodrigo O Perez. What more do we want from neoadjuvant treatment strategies in rectal cancer?. Colorectal Cancer 2015; 4(1): 1 doi: 10.2217/crc.15.5
|
| 19 |
Margaret Lee, Peter Gibbs, Rachel Wong. Multidisciplinary Management of Locally Advanced Rectal Cancer—An Evolving Landscape?. Clinical Colorectal Cancer 2015; 14(4): 251 doi: 10.1016/j.clcc.2015.06.002
|
| 20 |
Sven de Mey, Heng Jiang, Hui Wang, Benedikt Engels, Thierry Gevaert, Inès Dufait, Olivier Feron, Joeri Aerts, Valeri Verovski, Mark De Ridder. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer. Radiotherapy and Oncology 2018; 127(3): 361 doi: 10.1016/j.radonc.2018.04.003
|
| 21 |
Vaneja Velenik, Vesna Zadnik, Mirko Omejc, Jan Grosek, Mojca Tuta. Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health-related quality of life in locally advanced rectal cancer: a prospective phase II CRAB trial. Radiology and Oncology 2020; 54(4): 461 doi: 10.2478/raon-2020-0043
|
| 22 |
Claus Rödel, Ralf Hofheinz, Emmanouil Fokas. Rectal cancer: Neoadjuvant chemoradiotherapy. Best Practice & Research Clinical Gastroenterology 2016; 30(4): 629 doi: 10.1016/j.bpg.2016.06.004
|
| 23 |
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, Cynthia Aristei, Carlotta Becherini, Liliana Belgioia, Michela Buglione, Luciana Caravatta, Rolando Maria D’Angelillo, Andrea Riccardo Filippi, Michele Fiore, Domenico Genovesi, Carlo Greco, Lorenzo Livi, Stefano Maria Magrini, Giulia Marvaso, Rosario Mazzola, Icro Meattini, Anna Merlotti, Isabella Palumbo, Stefano Pergolizzi, Sara Ramella, Umberto Ricardi, Elvio Russi, Marco Trovò, Alessandro Sindoni, Vincenzo Valentini, Renzo Corvò. Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. Critical Reviews in Oncology/Hematology 2019; 134: 104 doi: 10.1016/j.critrevonc.2018.11.006
|